The entrepreneurial scientist

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Alok Tayi, Vice President of Life Sciences at Egnyte and the founder of the Biotech 2050 podcast. Alok has a very impressive academic and entrepreneurial background in life sciences, before running the fast-growing life science division at Egnyte, he was a Co-Founder of PreScouter and TetraScience, raising millions along the way. Having completed a postdoctoral fellowship at Harvard University, he has also been published in Forbes and Nature.

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain (and a whole loaf more) with Alok, covering how he founded, built and scaled two life science software companies… and then did it all over again as a vertical of a larger organisation. Alok shares the lessons he learned while raising millions in VC capital and the value of building relationships early on. He explains how CDMOs and CROs can become more strategic with biotech clients by seeing themselves as data and knowhow specialists. Finally, Raman and Alok discuss the journey of the contract services space and how the landscape has shifted from a largely transactional rigid business to becoming the foundational bedrock of the life science domain. 

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also love a positive rating! Molecule to Market is sponsored and funded by ramarketing, an international content, design and digital agency that helps companies get noticed, raise profile and generate leads in life sciences.